MedicineOncologyPreventive MedicineCancer ControlCancer PreventionCancer ScreeningCervical CancerCervical Disease PreventionCervical Intraepithelial NeoplasiaCervical LesionsCervical PathologyHuman Papillomavirus InfectionCervical Cancer ScreeningHpv ScreeningHuman Papillomavirus PreventionHuman Papillomavirus ScreeningMedical TrainingPapanicolaou TestPreventable MortalityTraining
Cervical cancer kills 260,000 women annually, and nearly 85% of these deaths occur in developing nations, where it is the leading cause of cancer deaths in women. Disparities of health and poverty play a large role in this high mortality rate. Whereas routine Papanicolaou and human papillomavirus (HPV) testing has dramatically reduced cervical cancer deaths in Western nations, without proper infrastructure, facilities, and medical training, the rates of cervical cancer in developing nations will remain high. Studies on HPV DNA testing and the low-technology method of "screen and treat" are promising. In addition, reducing the cost and increasing the availability of HPV vaccines in developing nations brings hope and promise to the next generation of women.
13
HPV Screening for Cervical Cancer in Rural India
Rengaswamy Sankaranarayanan, Bhagwan M. Nene, Surendra S. Shastri et al. · New England Journal of Medicine · 2009 · 1.3K citations
Screen-and-Treat Approaches for Cervical Cancer Prevention in Low-Resource Settings
Lynette Denny, Louise Kuhn, Michelle De Souza et al. · JAMA · 2005 · 357 citations
Medicine, Gynecology, Oncology +17